1
EXHIBIT 10.(ix)
VIRAGEN TECHNOLOGY, INC.
▇▇▇ ▇▇ ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇
▇▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇
PHONE: (▇▇▇) ▇▇▇-▇▇▇▇ FAX: (▇▇▇) ▇▇▇-▇▇▇▇
September 29, 1997
Viragen (Scotland) Ltd.
▇▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇
▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇
RE: LICENSING AGREEMENT DATED JULY 12, 1995
Gentlemen:
Reference is made to that Licensing Agreement dated July 12, 1995 (the
"Agreement"). We hereby amend paragraph 8(a)(i) and 8(a)(ii) such that the
$2,000,000 initial royalty previously paid by you will fulfill the obligation
of Viragen (Scotland) Ltd. through October 31, 1998 and no further royalty
payment will be due prior to November 1, 1998.
In addition, the parties agree that if the remaining technology is not
transferred to Viragen (Scotland) Ltd., no additional royalty payment will be
due to us, and Viragen Technology, Inc. will refund the aforementioned
$2,000,000 payment.
Very truly yours,
VIRAGEN TECHNOLOGY, INC.
By: /s/ ▇▇▇▇▇▇ ▇▇▇▇▇
---------------------------------
President
ACCEPTED AND AGREED
VIRAGEN (SCOTLAND) LTD.
By: /s/ ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇
----------------------------------
Director
